|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-7-6
|
|
pubmed:abstractText |
Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels. Limited information is available regarding the impact of this approach on either quality of life (QOL) or need for invasive follow-up in this group of women.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:BarakatRichard RRR,
pubmed-author:BrownCarol LCL,
pubmed-author:CastielMercedesM,
pubmed-author:GoldfrankDeborahD,
pubmed-author:HannLucy ELE,
pubmed-author:HensleyMartee LML,
pubmed-author:HurleyKaren EKE,
pubmed-author:KauffNoah DND,
pubmed-author:LevGaliG,
pubmed-author:OffitKennethK,
pubmed-author:OstroffJamie SJS,
pubmed-author:RobsonMark EME
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
314-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15948173-CA-125 Antigen,
pubmed-meshheading:15948173-Family Health,
pubmed-meshheading:15948173-Female,
pubmed-meshheading:15948173-Follow-Up Studies,
pubmed-meshheading:15948173-Genetic Predisposition to Disease,
pubmed-meshheading:15948173-Humans,
pubmed-meshheading:15948173-Middle Aged,
pubmed-meshheading:15948173-Ovarian Neoplasms,
pubmed-meshheading:15948173-Prospective Studies,
pubmed-meshheading:15948173-Quality of Life,
pubmed-meshheading:15948173-Ultrasonography, Interventional
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-up.
|
|
pubmed:affiliation |
Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. kauffn@mskcc.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
